LDN for Fibromyalgia – the ultimate compilation on the medicine that changed my life

Spread the love

It’s my pleasure to share resources that can help you. Low dose Naltrexone, LDN for fibromyalgia, is a medicine that has changed my life. It’s improved almost every metric there is with fibromyalgia.

I want to share all the information possible so that you can consider it for yourself.

It doesn’t help everyone, but it does help a large percentage of us to one degree or another. The thing that puts it over and above the other medicines is the low side-effect profile, the long history of use and the cost (it’s off label and therefore less costly).

LDN for fibromyalgia

I share here the videos and posts I have created about it so far to help you.

What is low dose Naltrexone? The brief beginner’s guide.

In this video I share what low dose naltrexone is – a small introduction to what it is, what low dose means, and what conditions it helps. This is part of a new series that is coming out and I will update as it is available.

Low Dose Naltrexone Changed My Life – my personal four year update

Recovery Factors Supplement for Fib...
Recovery Factors Supplement for Fibromyalgia: Recovery Factors Review

In this video I share my four year update on LDN. Spoiler alert – it changed my life. I share what it has done for me.

Low Dose Naltrexone Four Year Update post

Low Dose Naltrexone for Fibromyalgia full training

In this video I share the details you need to know about low dose Naltrexone for fibromyalgia. Get yourself a cuppa, a notebook, a heating pad and relax.

Further reading about LDN for Fibromyalgia

LDN for Fibromyalgia the beginning of the experiment

LDN for Fibromyalgia 16 week update

Low Dose Naltrexone for Fibromyalgia 1 year update

LDN new research coming

Low dose naltrexone training

Key Resource about LDN

LDN Research Trust – this is the place to start with information, education and research about LDN.

ldn for fibromyalgia

Have you tried LDN? Did it help you?

Leave a Reply

Your email address will not be published.